Andrew Garfield
Directeur des opérations chez Sapphiros
Profil
Andrew Garfield is currently working as the Vice President-Operations at Sapphiros since 2023.
Prior to this, he worked as the Senior Vice President-Global Operations at Smith & Nephew plc.
Postes actifs de Andrew Garfield
| Sociétés | Poste | Début |
|---|---|---|
Sapphiros
 Sapphiros Packaged SoftwareTechnology Services Sapphiros is a privately held consumer diagnostics platform company that invests in growth-stage diagnostic companies. Sapphiros is based in Boston, MA and has subsidiaries in the United Kingdom. The company aims to bridge the gap between present and future by focusing on innovative, patient-centric technologies. Sapphiros' portfolio of capabilities and technologies includes novel sample collection, next generation diagnostics, computational biology, and printed electronics, which help consumers access important diagnostic results quickly. The company empowers exceptional entrepreneurs with the full strength of the platform's resources, capital, and expertise to accelerate and enhance growth and impact. The company was founded by Niall Antony Armes and Namal Nawana. Mark Gladwell has been the CEO of the company since 2021. | Directeur des opérations | 17/07/2023 |
Anciens postes connus de Andrew Garfield
| Sociétés | Poste | Fin |
|---|---|---|
| SMITH & NEPHEW PLC | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SMITH & NEPHEW PLC | Health Technology |
| Entreprise privées | 1 |
|---|---|
Sapphiros
Sapphiros Packaged SoftwareTechnology Services Sapphiros is a privately held consumer diagnostics platform company that invests in growth-stage diagnostic companies. Sapphiros is based in Boston, MA and has subsidiaries in the United Kingdom. The company aims to bridge the gap between present and future by focusing on innovative, patient-centric technologies. Sapphiros' portfolio of capabilities and technologies includes novel sample collection, next generation diagnostics, computational biology, and printed electronics, which help consumers access important diagnostic results quickly. The company empowers exceptional entrepreneurs with the full strength of the platform's resources, capital, and expertise to accelerate and enhance growth and impact. The company was founded by Niall Antony Armes and Namal Nawana. Mark Gladwell has been the CEO of the company since 2021. | Technology Services |